Introduction
Methods
Subjects
Design
Statistical Analysis
Results
SGLT2i Improved Metabolic Parameters Among Chinese Participants with T2DM
Patient parameters | Measurement time point | Mean change from baseline (95% CI) | p value | |
---|---|---|---|---|
Baseline | 6 months post treatment initiation | |||
BW (kg) | 81.1 ± 18.1 | 79.5 ± 18.1 | − 1.6 (− 2.2, − 1.1) | < 0.001* |
BMI (Kg/m2) | 30.5 ± 5.76 | 29.9 ± 5.75 | − 0.6 (− 0.8, − 0.4) | < 0.001* |
SBP (mmHg) | 138 ± 19.0 | 132 ± 18.0 | − 5.3 (− 9.1, − 1.5) | 0.006* |
DBP(mmHg) | 77.4 ± 10.5 | 75.9 ± 11.2 | − 1.5 (− 3.7, 0.6) | 0.155 |
FPG (mmol/L) | 9.12 ± 2.73 | 7.20 ± 1.91 | − 1.9 (− 2.5, − 1.4) | < 0.001* |
HbA1c (%) | 8.56 ± 1.35 | 7.55 ± 0.90 | − 1.0 (− 1.2, − 0.8) | < 0.001* |
ALT (U/L) | 40.3 ± 28.0 | 29.0 ± 14.1 | − 11.3 (− 15.1, − 7.6) | < 0.001* |
AST (U/L) | 28.2 ± 13.2 | 23.1 ± 7.44 | − 5.1 (− 7.1, − 3.1) | < 0.001* |
Albumin (g/L) | 43.3 ± 3.11 | 43.9 ± 3.05 | 0.6 (0.1, 1.1) | 0.017* |
TC (mmol/L) | 3.95 ± 0.87 | 3.96 ± 0.85 | 0.01 (− 0.12, 0.13) | 0.887 |
TG (mmol/L) | 1.84 ± 1.43 | 1.68 ± 1.20 | − 0.16 (− 0.34. 0.03) | 0.098 |
HDL (mmol/L) | 1.10 ± 0.29 | 1.14 ± 0.27 | 0.04 (0.003, 0.08) | 0.033* |
LDL (mmol/L) | 2.10 ± 0.69 | 2.07 ± 0.67 | − 0.03 (− 0.13, 0.07) | 0.572 |
eGFR (ml/min/1.73 m2) | 91.3 ± 19.6 | 89.7 ± 20.6 | − 1.6 (− 2.9, − 0.3) | 0.016* |
SGLT2i Ameliorated Hepatic Dysfunction Among Chinese Participants with T2DM
Patients parameters |
R
| p value |
---|---|---|
Baseline variables | ||
BW | 0.231 | 0.014* |
ALTa | 0.614 | < 0.001* |
ASTa | 0.401 | < 0.001* |
Albumina | 0.088 | 0.381 |
HbA1c | 0.007 | 0.938 |
FPG | − 0.026 | 0.795 |
SBP | 0.095 | 0.325 |
eGFR (ml/min/1.73 m2) | 0.216 | 0.023* |
Change from baseline variablesa | ||
BW | 0.031 | 0.743 |
AST | 0.465 | < 0.001* |
Albumin | 0.083 | 0.411 |
HbA1c | 0.192 | 0.043* |
FPG | 0.248 | 0.014* |
SBP | 0.003 | 0.978 |
eGFR (ml/min/1.73 m2) | − 0.150 | 0.122 |
Changes in clinical variablesa | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|
Standardized beta | Beta (95% CI) | p value | Standardized beta | Beta (95% CI) | p value | |
HbA1c in Model | ||||||
Weight | 0.007 | 0.067 (− 1.711, 1.845) | 0.940 | – | – | – |
Albumin | 0.122 | 0.713 (− 0.400, 1.826) | 0.207 | – | – | – |
HbA1c | 0.190 | 0.510 (0.001, 1.018) | 0.049* | 0.192 | 0.514 (0.017, 1.011) | 0.043* |
SBP | − 0.008 | − 0.019 (− 0.481, 0.443) | 0.936 | – | – | – |
eGFR | − 0.149 | − 0.535 (− 1.219, 0.148) | 0.124 | – | – | – |
Fasting glucose in Model | ||||||
Weight | − 0.003 | − 0.026 (− 1.793, 1.740) | 0.976 | – | – | – |
Albumin | 0.112 | 0.656 (− 0.443, 1.755) | 0.239 | – | – | – |
FG | 0.230 | 0.252 (0.048, 0.456) | 0.016* | 0.232 | 0.255 (0.053, 0.456) | 0.014* |
Systolic BP | 0.021 | 0.052 (− 0.405, 0.508) | 0.822 | – | – | – |
eGFR | − 0.155 | − 0.557 (− 1.233, 0.119) | 0.105 | – | – | – |